DC/MM Fusion Vaccine

BIOLOGICAL2 trials

Sponsors

David Avigan

Conditions

Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma

Phase 1

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

RecruitingNCT06799026

David AviganMultiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma

Start: 2025-01-31End: 2030-09-01Target: 25Updated: 2026-05-07

DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

RecruitingNCT07377435

David AviganMultiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma

Start: 2026-01-30End: 2032-03-01Target: 25Updated: 2026-05-08